» Articles » PMID: 36172186

in Cancer: Potential Role in Regulating MicroRNAs and Epigenetic Enzymes

Overview
Journal Front Pharmacol
Date 2022 Sep 29
PMID 36172186
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are small non-coding RNAs that play important roles in gene regulation by influencing the translation and longevity of various target mRNAs and the expression of various target genes as well as by modifying histones and DNA methylation of promoter sites. Consequently, when dysregulated, microRNAs are involved in the development and progression of a variety of diseases, including cancer, by affecting cell growth, proliferation, differentiation, migration, and apoptosis. Preparations from the dried root and rhizome of (Lamiaceae), also known as red sage or danshen, are widely used for treating cardiovascular diseases. Accumulating data suggest that certain bioactive constituents of this plant, particularly tanshinones, have broad antitumor effects by interfering with microRNAs and epigenetic enzymes. This paper reviews the evidence for the antineoplastic activities of constituents by causing or promoting cell cycle arrest, apoptosis, autophagy, epithelial-mesenchymal transition, angiogenesis, and epigenetic changes to provide an outlook on their future roles in the treatment of cancer, both alone and in combination with other modalities.

Citing Articles

3-Hydroxytanshinone Inhibits the Activity of Hypoxia-Inducible Factor 1-α by Interfering with the Function of α-Enolase in the Glycolytic Pathway.

Son T, Kim S, Shin H, Kim D, Kim H, Choi Y Molecules. 2024; 29(10).

PMID: 38792080 PMC: 11123766. DOI: 10.3390/molecules29102218.

References
1.
Zhou X, Lv L, Tan Y, Zhang Z, Wei S, Xiao S . Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation). Brain Res. 2021; 1766:147515. DOI: 10.1016/j.brainres.2021.147515. View

2.
Ryu S, Park S, Lim W, Song G . Effects of luteolin on canine osteosarcoma: Suppression of cell proliferation and synergy with cisplatin. J Cell Physiol. 2018; 234(6):9504-9514. DOI: 10.1002/jcp.27638. View

3.
Sui H, Zhao J, Zhou L, Wen H, Deng W, Li C . Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Cancer Lett. 2017; 403:86-97. DOI: 10.1016/j.canlet.2017.05.013. View

4.
Lakshminarasimhan R, Liang G . The Role of DNA Methylation in Cancer. Adv Exp Med Biol. 2016; 945:151-172. PMC: 7409375. DOI: 10.1007/978-3-319-43624-1_7. View

5.
Li X, Jia Q, Zhou Y, Jiang X, Song L, Wu Y . Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis. Exp Hematol Oncol. 2022; 11(1):2. PMC: 8781032. DOI: 10.1186/s40164-022-00255-4. View